BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8320865)

  • 1. Effects of pretreatment with mydriatics on intraocular penetration of 0.1% pranoprofen.
    Ogawa T; Ohara K; Shimizu H
    Jpn J Ophthalmol; 1993; 37(1):47-55. PubMed ID: 8320865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of pre-instilled mydriatics on the intraocular concentration and anti-inflammatory action of topical 0.1% pranoprofen (3)--study on permeability factor].
    Ogawa T; Ohara K; Shimizu H
    Nippon Ganka Gakkai Zasshi; 1992 Nov; 96(11):1379-86. PubMed ID: 1476068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of pre-instilled mydriatics on the intraocular concentration and anti-inflammatory action of topical 0.1% pranoprofen (2)--Study on multiple dosing].
    Ogawa T; Ohara K; Shimizu H
    Nippon Ganka Gakkai Zasshi; 1992 Sep; 96(9):1079-84. PubMed ID: 1414697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the corneal epithelium on the intraocular penetration of fluoroquinolone ophthalmic solution.
    Fukuda M; Inoue A; Sasaki K; Takahashi N
    Jpn J Ophthalmol; 2004; 48(2):93-6. PubMed ID: 15060787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probenecid-induced changes in the clearance of pranoprofen enantiomers.
    Imai T; Nomura T; Otagiri M
    Chirality; 2003 May; 15(4):318-23. PubMed ID: 12666238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of pre-instilled mydriatics on the intraocular concentration and anti-inflammatory action of topical 0.1% pranoprofen].
    Ogawa T; Ohara K; Ohira M
    Nippon Ganka Gakkai Zasshi; 1988 Sep; 92(9):1510-9. PubMed ID: 3265023
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of pranoprofen in the elderly.
    Kajiyama H; Fujimura A; Ebihara A; Hino Y
    Int J Clin Pharmacol Res; 1991; 11(3):123-7. PubMed ID: 1809698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye.
    Stadtbäumer K; Frommlet F; Nell B
    Vet Ophthalmol; 2006; 9(4):233-7. PubMed ID: 16771758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin.
    Di Colo G; Zambito Y; Burgalassi S; Nardini I; Saettone MF
    Int J Pharm; 2004 Apr; 273(1-2):37-44. PubMed ID: 15010128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of potentiating effect of a drop of lignocaine on tropicamide-induced mydriasis.
    Ghose S; Garodia VK; Sachdev MS; Kumar H; Biswas NR; Pandey RM
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1581-5. PubMed ID: 11381064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tissue culture of bovine lens as an in vitro model for posterior capsule opacification and the effects of pranoprofen on the cell confluence].
    Li QM; Wang MH; Zheng GY
    Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):48-53. PubMed ID: 16638281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular pharmacokinetics and availability of topically applied baicalein in rabbits.
    Zhang L; Zhang J; Wang L; Xia H
    Curr Eye Res; 2009 Apr; 34(4):257-63. PubMed ID: 19373573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of the ocular bioavailability of timolol by sorbic acid.
    Higashiyama M; Inada K; Ohtori A; Tojo K
    Int J Pharm; 2004 Mar; 272(1-2):91-8. PubMed ID: 15019072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination solution for routine pupillary dilation.
    Krumholz DM; Portello JK; Rosenfield M; Rosenbaum JD
    Optometry; 2006 Jul; 77(7):350-3. PubMed ID: 16814239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation of diclofenac sodium liposomes and its ocular pharmacokinetics].
    Sun KX; Wang AP; Huang LJ; Liang RC; Liu K
    Yao Xue Xue Bao; 2006 Nov; 41(11):1094-8. PubMed ID: 17262954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intraocular penetration of topical lomefloxacin in rabbit's eyes].
    Zhang Y; Chen Y; Chen Z
    Zhonghua Yan Ke Za Zhi; 1998 May; 34(3):211-4. PubMed ID: 11877193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin and tropicamide accumulate in the contralateral, untreated eye of rats following ipsilateral topical administration by a mechanism that does not involve systemic uptake.
    Patsiopoulos G; Lam V; Lake S; Koevary SB
    Optometry; 2003 Apr; 74(4):226-32. PubMed ID: 12703687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental comparative study of the anti-inflammatory effectiveness of pranoprofen].
    Andrés RC; Moreno OR; Marín Del Tiempo D; Aragués AR; Llorens VP; Gonzalvo F; López FH
    Arch Soc Esp Oftalmol; 2000; 75(5):327-32. PubMed ID: 11151170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into mechanisms of pranoprofen-induced apoptosis and necroptosis in human corneal stromal cells.
    Lin Y; Yu M; Fan T
    Toxicol Lett; 2020 Mar; 320():9-18. PubMed ID: 31765691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Availability of TPD ophthalmic solution (mixture of Mydrin-P solution, Neosynesin Kowa solution, and Diclod solution) in regard to the corneal barrier function--clinical evaluation for vitrectomy in patients with diabetic retinopathy].
    Tokuda K; Hirowatari T; Kamei Y; Miyazaki Y; Matsubara M
    Nippon Ganka Gakkai Zasshi; 2002 Oct; 106(10):648-53. PubMed ID: 12420376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.